↓ Skip to main content

Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial

Overview of attention for article published in BMC Gastroenterology, February 2010
Altmetric Badge

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
2 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial
Published in
BMC Gastroenterology, February 2010
DOI 10.1186/1471-230x-10-21
Pubmed ID
Authors

Fabrizio Mecenate, Adriano M Pellicelli, Giuseppe Barbaro, Mario Romano, Angelo Barlattani, Ettore Mazzoni, Maria Elena Bonaventura, Lorenzo Nosotti, Pasquale Arcuri, Antonio Picardi, Giorgio Barbarini, Cecilia D'Ambrosio, Amerigo Paffetti, Arnaldo Andreoli, Fabrizio Soccorsi, the Club Epatologi Ospedalieri (CLEO) Group

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 2 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 50%
Unknown 1 50%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 4 200%
Student > Bachelor 4 200%
Professor > Associate Professor 4 200%
Researcher 3 150%
Student > Ph. D. Student 3 150%
Other 8 400%
Readers by discipline Count As %
Medicine and Dentistry 13 650%
Agricultural and Biological Sciences 5 250%
Pharmacology, Toxicology and Pharmaceutical Science 2 100%
Economics, Econometrics and Finance 2 100%
Social Sciences 2 100%
Other 2 100%